Patienter i behandling med Trudexa havde signifikant større forbedringer ved uge 12, som blev l
Trudexa treated patients had significantly greater improvement at Week 12 which was maintained through Week 24 in both the SF36 and Ankylosing Spondylitis Quality of Life Questionnaire